{"id":"https://openalex.org/W2016025876","doi":"https://doi.org/10.1210/jc.2007-1912","title":"Modulation of 11\u03b2-Hydroxysteroid Dehydrogenase (11\u03b2HSD) Activity Biomarkers and Pharmacokinetics of PF-00915275, a Selective 11\u03b2HSD1 Inhibitor","display_name":"Modulation of 11\u03b2-Hydroxysteroid Dehydrogenase (11\u03b2HSD) Activity Biomarkers and Pharmacokinetics of PF-00915275, a Selective 11\u03b2HSD1 Inhibitor","alternate_titles":[],"publication_year":2007,"publication_date":"2007-11-07","ids":{"openalex":"https://openalex.org/W2016025876","doi":"https://doi.org/10.1210/jc.2007-1912","mag":"2016025876","pmid":"https://pubmed.ncbi.nlm.nih.gov/17986636"},"language":"en","primary_location":{"id":"doi:10.1210/jc.2007-1912","doi":"https://doi.org/10.1210/jc.2007-1912","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.2007-1912","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2016025876"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112255294","display_name":"Rachel Courtney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rachel Courtney","raw_affiliation_strings":["Clinical Pharmacology (R.C., M.T.), Pfizer Inc., La Jolla, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology (R.C., M.T.), Pfizer Inc., La Jolla, California 92121","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050877182","display_name":"Paul M. Stewart","orcid":"https://orcid.org/0000-0002-1749-9640","observed_orcids":["https://orcid.org/0000-0002-1749-9640"]},"institutions":[{"id":"https://openalex.org/I2799307867","display_name":"Queen Elizabeth Hospital Birmingham","ror":"https://ror.org/048emj907","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049","https://openalex.org/I2799307867"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul M. Stewart","raw_affiliation_strings":["Queen Elizabeth Hospital (P.M.S.), University of Birmingham, Birmingham B15 2TT, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Queen Elizabeth Hospital (P.M.S.), University of Birmingham, Birmingham B15 2TT, United Kingdom","institution_ids":["https://openalex.org/I2799307867","https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014294005","display_name":"Melvin Toh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Melvin Toh","raw_affiliation_strings":["Clinical Pharmacology (R.C., M.T.), Pfizer Inc., La Jolla, California 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology (R.C., M.T.), Pfizer Inc., La Jolla, California 92121","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084220816","display_name":"Marie-Noella Ndongo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114767","display_name":"Pfizer (Belgium)","ror":"https://ror.org/01zk1vt68","country_code":"BE","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I4210114767"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Marie-Noella Ndongo","raw_affiliation_strings":["Clinical Research (M.-N.N.), Pfizer Inc., B-1050 Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research (M.-N.N.), Pfizer Inc., B-1050 Brussels, Belgium","institution_ids":["https://openalex.org/I4210114767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037077908","display_name":"Roberto A. Calle","orcid":"https://orcid.org/0000-0001-6577-5657","observed_orcids":["https://orcid.org/0000-0001-6577-5657"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roberto A. Calle","raw_affiliation_strings":["Cardiovascular and Metabolic Diseases (R.A.C., B.H.), Pfizer Inc., Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Diseases (R.A.C., B.H.), Pfizer Inc., Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072950568","display_name":"Boaz Hirshberg","orcid":"https://orcid.org/0000-0003-2829-3602","observed_orcids":["https://orcid.org/0000-0003-2829-3602"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Boaz Hirshberg","raw_affiliation_strings":["Cardiovascular and Metabolic Diseases (R.A.C., B.H.), Pfizer Inc., Groton, Connecticut 06340"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Diseases (R.A.C., B.H.), Pfizer Inc., Groton, Connecticut 06340","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5072950568","https://openalex.org/A5112255294"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":3.3582,"has_fulltext":false,"cited_by_count":96,"citation_normalized_percentile":{"value":0.92069478,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"93","issue":"2","first_page":"550","last_page":"556"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":0.7788000106811523,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":0.7788000106811523,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12421","display_name":"Adrenal Hormones and Disorders","score":0.15049999952316284,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.016300000250339508,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/11beta-hydroxysteroid-dehydrogenase-type-1","display_name":"11\u03b2-hydroxysteroid dehydrogenase type 1","score":0.9070000052452087},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8149999976158142},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.5830000042915344},{"id":"https://openalex.org/keywords/glucocorticoid-metabolism","display_name":"glucocorticoid metabolism","score":0.7900000214576721},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.890999972820282},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9470000267028809},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.5320000052452087},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.8169999718666077},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.7080000042915344},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.453000009059906}],"concepts":[{"id":"https://openalex.org/C2780484280","wikidata":"https://www.wikidata.org/wiki/Q423185","display_name":"Cortisone","level":2,"score":0.7030360102653503},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6808527112007141},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6663025617599487},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6157194375991821},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5642527937889099},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.5108897089958191},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.49613723158836365},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49154791235923767},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4875916838645935},{"id":"https://openalex.org/C2776715498","wikidata":"https://www.wikidata.org/wiki/Q11426176","display_name":"Prednisolone","level":2,"score":0.46123623847961426},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.44985756278038025},{"id":"https://openalex.org/C166075782","wikidata":"https://www.wikidata.org/wiki/Q171604","display_name":"11\u03b2-hydroxysteroid dehydrogenase type 1","level":4,"score":0.4454079866409302},{"id":"https://openalex.org/C2780841215","wikidata":"https://www.wikidata.org/wiki/Q422549","display_name":"Glucocorticoid","level":2,"score":0.42225801944732666},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.41451993584632874},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41240882873535156},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.32163935899734497},{"id":"https://openalex.org/C2776317432","wikidata":"https://www.wikidata.org/wiki/Q412547","display_name":"Dehydrogenase","level":3,"score":0.20299223065376282},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12901949882507324},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.11993387341499329},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07652536034584045},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D003348","descriptor_name":"Cortisone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003348","descriptor_name":"Cortisone","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006854","descriptor_name":"Hydrocortisone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006854","descriptor_name":"Hydrocortisone","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D007030","descriptor_name":"Hypothalamo-Hypophyseal System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010913","descriptor_name":"Pituitary-Adrenal System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011239","descriptor_name":"Prednisolone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D043205","descriptor_name":"11-beta-Hydroxysteroid Dehydrogenase Type 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D043205","descriptor_name":"11-beta-Hydroxysteroid Dehydrogenase Type 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1210/jc.2007-1912","doi":"https://doi.org/10.1210/jc.2007-1912","is_oa":false,"landing_page_url":"https://doi.org/10.1210/jc.2007-1912","pdf_url":null,"source":{"id":"https://openalex.org/S205775358","display_name":"The Journal of Clinical Endocrinology & Metabolism","issn_l":"0021-972X","issn":["0021-972X","1945-7197"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Endocrinology &amp; Metabolism","raw_type":"journal-article"},{"id":"pmid:17986636","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17986636","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical endocrinology and metabolism","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/5284f7a0-fb3e-43be-a671-c397a4c5ae84","doi":null,"is_oa":false,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/5284f7a0-fb3e-43be-a671-c397a4c5ae84","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Courtney, R, Stewart, P, Toh, M, Ndongo, MN, Calle, RA & Hirshberg, B 2008, 'Modulation of 11 beta-hydroxysteroid dehydrogenase (11 beta HSD) activity biomarkers and pharmacokinetics of PF-00915275, a selective 11 beta HSD1 inhibitor', Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 2, pp. 550-556. https://doi.org/10.1210/jc.2007-1912","raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1986842715","https://openalex.org/W2016295022","https://openalex.org/W2020267609","https://openalex.org/W2046645679","https://openalex.org/W2072352119","https://openalex.org/W2092020543","https://openalex.org/W2100159933","https://openalex.org/W2106964822","https://openalex.org/W2117268230","https://openalex.org/W2130203112","https://openalex.org/W2150654293","https://openalex.org/W2154972651","https://openalex.org/W2158530640","https://openalex.org/W2164058090","https://openalex.org/W2164828732","https://openalex.org/W2165698647","https://openalex.org/W2999510508","https://openalex.org/W6646888558","https://openalex.org/W6732478359"],"related_works":["https://openalex.org/W2113167588","https://openalex.org/W2087215750","https://openalex.org/W2331287359","https://openalex.org/W2017417924","https://openalex.org/W2010208330","https://openalex.org/W2205763511","https://openalex.org/W2085231533","https://openalex.org/W2006176887","https://openalex.org/W2101909530","https://openalex.org/W2069819370"],"abstract_inverted_index":{"CONTEXT:":[0],"11beta-Hydroxysteroid":[1],"dehydrogenase":[2],"type":[3,14],"1":[4],"(11betaHSD1)":[5],"is":[6,36,40,255],"a":[7,94,108,147,196,256],"promising":[8],"target":[9],"for":[10],"the":[11,20,27,47,58,69,82,119,135,182,200,243,248],"treatment":[12],"of":[13,23,34,74,84,124,145,158,210,226,242],"2":[15],"diabetes":[16],"mellitus.":[17],"11betaHSD1":[18,35,149,258],"catalyzes":[19],"intracrine":[21],"conversion":[22],"inactive":[24],"cortisone":[25,87,222],"to":[26,44,56,77,187,204,219],"active":[28],"glucocorticoid":[29],"cortisol.":[30],"OBJECTIVE:":[31],"Demonstrating":[32],"inhibition":[33,209],"challenging":[37],"because":[38],"there":[39,194],"no":[41],"accessible":[42],"way":[43],"directly":[45],"assess":[46,57],"enzyme":[48,59],"activity":[49],"in":[50,61,79,89,107,118,179,199],"vivo.":[51],"Thus,":[52],"it":[53],"was":[54,93,105,169,189,195,234],"proposed":[55],"activity,":[60],"an":[62,224],"indirect":[63],"fashion,":[64],"using":[65],"two":[66],"biomarker":[67],"methods:":[68],"prednisolone":[70,78,188,244],"generation":[71,245],"study":[72,104],"(conversion":[73],"oral":[75,156,166],"prednisone":[76,129],"plasma)":[80],"and":[81,86,128,143,162,174,193,247],"ratio":[83,206],"cortisol":[85,218],"metabolites":[88],"urine.":[90],"DESIGN:":[91],"This":[92],"phase":[95],"1,":[96],"double-blind,":[97],"placebo-controlled,":[98],"randomized,":[99],"multiple-dose":[100],"study.":[101,120,136],"SETTING:":[102],"The":[103,215,240],"conducted":[106],"clinical":[109],"research":[110],"unit.":[111],"PARTICIPANTS:":[112],"Sixty":[113],"healthy":[114],"adult":[115],"volunteers":[116],"participated":[117],"INTERVENTION:":[121],"Oral":[122],"doses":[123,157,238],"PF-00915275":[125,159,168,233,254],"(0.3-15":[126],"mg)":[127,131],"(10":[130],"were":[132,151,160],"administered":[133],"during":[134],"MAIN":[137],"OUTCOME":[138],"MEASURES:":[139],"Safety,":[140],"tolerability,":[141],"pharmacokinetics,":[142],"pharmacodynamics":[144],"PF-00915275,":[146],"selective":[148,257],"inhibitor,":[150],"measured.":[152],"RESULTS:":[153],"Overall,":[154],"multiple":[155],"safe":[161,235],"well":[163],"tolerated.":[164],"After":[165],"administration,":[167],"rapidly":[170],"absorbed,":[171],"slowly":[172],"eliminated,":[173],"generally":[175],"displayed":[176],"dose-proportional":[177],"increases":[178],"exposure.":[180],"At":[181],"15-mg":[183],"dose,":[184],"mean":[185],"exposure":[186],"reduced":[190],"by":[191],"37%,":[192],"dose-dependent":[197],"fall":[198],"5alpha-tetrahydrocortisol":[201],"+":[202],"5beta-tetrahydrocortisol":[203],"tetrahydrocortisone":[205],"with":[207],"maximum":[208],"26%":[211],"after":[212],"14":[213],"d.":[214],"urinary":[216,220,249],"free":[217,221],"ratio,":[223],"indicator":[225],"11betaHSD2":[227],"inhibition,":[228],"did":[229],"not":[230],"change.":[231],"CONCLUSION:":[232],"at":[236],"all":[237],"tested.":[239],"results":[241],"test":[246],"metabolite":[250],"ratios":[251],"confirm":[252],"that":[253],"inhibitor.":[259]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2016025876","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":10}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
